Regeneron

Sanofi/Regeneron’s Libtayo set for new skin cancer use
Sanofi/Regeneron’s Libtayo set for new skin cancer use
Pharmaforum
Sanofi
Regeneron
Libtayo
clinical trials
skin cancer
Flag link:
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Pharmaceutical Business Review
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
breakthrough status
Flag link:
Novartis says Beovu matched rival Eylea in visual acuity in eye disease
Novartis says Beovu matched rival Eylea in visual acuity in eye disease
Pharma Live
Novartis
Beovu
Eylea
Regeneron
diabetic macular edema
clinical trials
Flag link:
Sanofi Halts Kevzara Tests for Covid as Drug Fails to Help
Sanofi Halts Kevzara Tests for Covid as Drug Fails to Help
Bloomberg
Sanofi
Regeneron
Kevzara
COVID-19
clinical trials
Flag link:
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Flag link:
Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail
Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail
Pharmaforum
AstraZeneca
Regeneron
antibody cocktail
clinical trials
COVID-19
Flag link:
Regeneron flashes ‘great advance' in the NEJM for that other cholesterol drug sitting at the FDA
Regeneron flashes ‘great advance' in the NEJM for that other cholesterol drug sitting at the FDA
Endpoints
Regeneron
inclisiran
RNAi
Novartis
New England Journal of Medicine
Flag link:
Regeneron, Roche team up in global deal on Covid-19 antibody cocktail
Regeneron, Roche team up in global deal on Covid-19 antibody cocktail
MedCity News
Roche
Regeneron
COVID-19
antibodies
antibody cocktail
Flag link:
Regeneron's Praluent sidekick nabs speedy FDA review, with February PDUFA date
Regeneron's Praluent sidekick nabs speedy FDA review, with February PDUFA date
Fierce Biotech
Regeneron
evicanumab
FDA
Homozygous Familial Hypercholesterolemia
Flag link:
Regeneron profit beats, expects early results from COVID-19 trials in September
Regeneron profit beats, expects early results from COVID-19 trials in September
Yahoo/Reuters
Regeneron
earnings
COVID-19
Flag link:
Regeneron says antibody cocktail prevents and treats coronavirus in animals
Regeneron says antibody cocktail prevents and treats coronavirus in animals
CNBC
Regeneron
antibodies
COVID-19
Flag link:
Regeneron pairs with BioNTech on melanoma immunotherapy
Regeneron pairs with BioNTech on melanoma immunotherapy
Pharmaforum
Regeneron
BioNTech
melanoma
Libtayo
vaccines
BNT111
MRNA
Flag link:
Will Regeneron Help Win the Fight Against COVID-19?
Will Regeneron Help Win the Fight Against COVID-19?
Motley Fool
Regeneron
clinical trials
antibodies
COVID-19
pandemic
Flag link:
Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
Fierce Pharma
Sanofi
Regeneron
Kevzara
clinical trials
COVID-19
Flag link:
BARDA, DoD give Regeneron $450M contract for Covid-19 antiviral drug
BARDA, DoD give Regeneron $450M contract for Covid-19 antiviral drug
MedCity News
Regeneron
Department of Defense
BARDA
REGN-COV2
government contracts
COVID-19
Flag link:
Regeneron Starts Late-Stage Trials of Coronavirus Cocktail
Regeneron Starts Late-Stage Trials of Coronavirus Cocktail
TheStreet.com
Regeneron
clinical trials
REGN-COV2
COVID-19
Flag link:
Regeneron's Arthritis Drug Fails COVID-19 Trial
Regeneron's Arthritis Drug Fails COVID-19 Trial
Motley Fool
Regeneron
Kevazara
COVID-19
pandemic
clinical trials
Flag link:
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
BioSpace
pharma industry
biotech
pandemic
COVID-19
hirings
AGC Biologics
Grail
Grifols
CRISPR Therapeutics
Sana Biotechnology
Point
Sanofi
Medpharm
Regeneron
Flag link:
Regeneron’s Billionaire Cofounder Criticized After ‘All Lives Matter’ Graduation Speech
Regeneron’s Billionaire Cofounder Criticized After ‘All Lives Matter’ Graduation Speech
Forbes
Regeneron
George Yancopoulos
racial diversity
Flag link:
Kiniksa preps BLA as Regeneron drug cruises to a PhIII win — shares soar
Kiniksa preps BLA as Regeneron drug cruises to a PhIII win — shares soar
Endpoints
Kiniksa Pharmaceuticals
Regeneron
Arcalyst
pericarditis
clinical trials
Flag link:

Pages